β(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical γ-aminobutyric acid release in vivo

Brain Research

Volumn 831, Issue 1-2, 1999, Pages 319-321

  Scali, Carla ^a   Prosperi, Costanza ^a   Giovannelli, Lisa ^a   Bianchi, Loria ^a   Pepeu, Giancarlo ^a   Casamenti, Fiorella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

(1 40); Aminobutyric acid release; Glutamic acid decarboxylase activity; Microglia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; AMYLOID BETA PROTEIN; ASPARTIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; POTASSIUM ION; TAURINE;

4 AMINOBUTYRIC ACID RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC NERVE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GABAERGIC SYSTEM; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MICROGLIA; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; GAMMA-AMINOBUTYRIC ACID; MALE; MICROGLIA; MICROINJECTIONS; NEUROTOXINS; PARIETAL LOBE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SUBSTANTIA INNOMINATA;

EID: 0033549259     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01492-4     Document Type: Article

References (13)

1. D.S. Auld, S. Kar, R. Quiron, β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?, Trends Neurosci. 21 (1998) 43-49.
2. F. Casamenti, C. Prosperi, C. Scali, L. Giovannelli, M.A. Colivicchi, M.S. Faussone-Pellegrini, G. Pepeu, Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and gamma-aminobutyric acid release in vivo: implication for Alzheimer's disease, Neuroscience 91 (1999) 831-842.
3. C.A. Frederickson Robert, Astroglia in Alzheimer's disease, Neurobiol. Aging 13 (1992) 239-253.
4. T.F. Freund, A.I. Gulyàs, GABAergic interneurons containing calbindin D28K or somatostatin are major targets of GABAergic basal forebrain afferents in the rat neocortex, J. Comp. Neurol. 314 (1991) 187-199.
5. L. Giovannelli, F. Casamenti, C. Scali, L. Bartolini, G. Pepeu, Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis, Neuroscience 66 (1995) 781-792.
6. L. Giovannelli, C. Scali, M.S. Faussone-Pellegrini, G. Pepeu, F. Casamenti, Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain, Neuroscience 87 (1998) 349-357.
7. K. Lenda, G. Sveneby, Rapid high performance liquid chromatographic determination of amino acids in synaptosomal extracts, J. Chromatogr. 198 (1980) 516-519.
8. G. Lombardi, R. Zanoni, F. Moroni, Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat, Eur. J. Pharmacol. 174 (1989) 123-125.
9. P.L. McGeer, E.G. McGeer, The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases, Brain Res. Rev. 21 (1995) 195-218.
10. P.L. McGeer, M. Schulzer, E.G. McGeer, Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies, Neurology 47 (1996) 425-432.
11. G. Pepeu, L. Giovannelli, F. Casamenti, C. Scali, Effects of β-amyloid (1-40) peptide injection in the nucleus basalis, in: R. Becker, E. Giacobini (Eds.), Alzheimer Disease: From Molecular Biology To Therapy, Birkhauser, Boston, 1996, pp. 81-85.
12. C.J. Pike, C.W. Cotman, Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid, Neuroscience 56 (1993) 269-274.
13. Timmerman, B.H.C. Westerink, Brain microdialysis of GABA and glutamate: what does it signify?, Synapse 27 (1997) 242-261.